Shree Ganesh Biotech India Ltd
₹ 0.59
0.00%
22 May
- close price
About
Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.[1]
Key Points
- Market Cap ₹ 23.5 Cr.
- Current Price ₹ 0.59
- High / Low ₹ 0.90 / 0.54
- Stock P/E 61.9
- Book Value ₹ 1.60
- Dividend Yield 0.00 %
- ROCE 0.80 %
- ROE 0.60 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Stock is trading at 0.37 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -22.0% over past five years.
- Company has a low return on equity of 0.68% over last 3 years.
- Working capital days have increased from 260 days to 861 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.68 | 2.12 | 8.54 | 7.86 | 5.87 | 2.47 | 17.21 | 72.64 | 62.45 | 20.28 | 22.96 | 4.97 | |
| 1.17 | 1.47 | 4.78 | 4.36 | 4.08 | 2.23 | 16.50 | 69.19 | 60.30 | 20.48 | 24.01 | 5.93 | |
| Operating Profit | 0.51 | 0.65 | 3.76 | 3.50 | 1.79 | 0.24 | 0.71 | 3.45 | 2.15 | -0.20 | -1.05 | -0.96 |
| OPM % | 30.36% | 30.66% | 44.03% | 44.53% | 30.49% | 9.72% | 4.13% | 4.75% | 3.44% | -0.99% | -4.57% | -19.32% |
| 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | -0.28 | 0.05 | 0.56 | 1.06 | 1.44 | 1.47 | |
| Interest | 0.07 | 0.07 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.34 | 0.55 | 3.73 | 3.50 | 1.79 | 0.24 | 0.43 | 3.50 | 2.71 | 0.86 | 0.39 | 0.51 |
| Tax % | 0.00% | 1.82% | 0.00% | 0.00% | 0.00% | 0.00% | 25.58% | 27.71% | 25.09% | 26.74% | 28.21% | 27.45% |
| 0.34 | 0.54 | 3.73 | 3.50 | 1.79 | 0.24 | 0.32 | 2.53 | 2.04 | 0.62 | 0.28 | 0.38 | |
| EPS in Rs | 0.09 | 0.15 | 1.01 | 0.95 | 0.04 | 0.01 | 0.01 | 0.06 | 0.05 | 0.02 | 0.01 | 0.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | -22% |
| 3 Years: | -57% |
| TTM: | -78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -6% |
| 3 Years: | -43% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -37% |
| 3 Years: | -17% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.83 | 1.83 | 1.83 | 1.83 | 19.93 | 19.93 | 19.93 | 19.93 | 39.86 | 39.86 | 39.86 | 39.86 |
| Reserves | 2.41 | 2.94 | 17.54 | 21.04 | 37.31 | 37.54 | 37.86 | 40.39 | 22.49 | 23.12 | 23.39 | 23.77 |
| 0.61 | 0.50 | 0.06 | 0.19 | 0.19 | 0.19 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.12 | 0.03 | 0.01 | 3.30 | 6.66 | 7.06 | 16.64 | 33.24 | 17.18 | 10.64 | 0.24 | 0.17 | |
| Total Liabilities | 4.97 | 5.30 | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 73.62 | 63.49 | 63.80 |
| 2.40 | 2.32 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 3.06 | 3.22 | 0.00 | 0.00 | 9.15 | 9.15 |
| 2.36 | 2.77 | 19.44 | 26.36 | 64.08 | 64.72 | 71.56 | 90.34 | 79.53 | 73.62 | 54.34 | 54.65 | |
| Total Assets | 4.97 | 5.30 | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 73.62 | 63.49 | 63.80 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.07 | -0.04 | -12.94 | 2.23 | -0.50 | -1.01 | 2.36 | 3.57 | 10.54 | 10.16 | -10.21 | -8.20 | |
| -0.11 | 0.00 | 2.53 | -2.36 | -32.07 | 0.99 | -2.36 | -3.37 | -10.09 | -10.21 | 9.80 | 8.19 | |
| 0.28 | -0.11 | 10.42 | 0.13 | 32.58 | 0.00 | 0.00 | -0.19 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.10 | -0.16 | 0.02 | 0.00 | 0.01 | -0.02 | 0.01 | 0.01 | 0.44 | -0.05 | -0.41 | 0.00 |
| Free Cash Flow | -0.07 | -0.04 | -10.62 | 2.23 | -0.51 | -1.01 | 2.36 | 3.57 | 10.54 | 10.16 | -10.21 | -8.20 |
| CFO/OP | -14% | -6% | -344% | 64% | -28% | -421% | 348% | 132% | 522% | -5,080% | 972% | 843% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 260.71 | 456.25 | 384.23 | 627.84 | 1,191.38 | 3,072.21 | 601.05 | 220.54 | 112.98 | 59.39 | 0.00 | 0.00 |
| Inventory Days | 483.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.59 | 846.14 |
| Days Payable | 46.27 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 697.69 | 456.25 | 384.23 | 627.84 | 1,191.38 | 3,072.21 | 601.05 | 220.54 | 112.98 | 59.39 | 46.59 | 846.14 |
| Working Capital Days | 310.68 | 380.50 | 383.81 | 475.99 | 779.12 | 2,036.32 | 249.20 | 53.71 | 12.80 | -132.11 | 50.08 | 860.72 |
| ROCE % | 9.04% | 12.25% | 30.45% | 16.47% | 4.45% | 0.42% | 1.23% | 5.92% | 4.42% | 1.37% | 0.62% | 0.80% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees absolute |
|
||||||||||
| Number of Shareholders absolute |
|||||||||||
| Trade Receivables Turnover Ratio times |
|||||||||||
| Segment Revenue Concentration (Hybrid Seeds) % |
|||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
4m - Annual Secretarial Compliance Report for FY 2025-26 दाखिल; no non-compliances observed.
-
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
14 May - Company reported no unutilised issue proceeds as of 31 March 2026.
- Regulation 33 Read With Regulation 30 Of SEBI (LODR) Regulations, 2015 ("Listing Regulations") 14 May
-
Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026.
14 May - Board approved audited FY26 standalone results; net profit ₹37.76 lakh, auditor gave unmodified opinion.
-
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
4 May - Board meeting on 14 May 2026 to approve audited standalone results for year ended 31 March 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1][2]
SGBL is engaged in the business of production,
processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc. The
company provides crop solutions to the farmer
by supplying high yielding hybrid seeds and crop management namely micro nutrients, bio
products etc.